Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 ganglioside

9 Mar 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cellular transport and secretion
Share to Lysosomal Storage Disorders Research
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 32165255
DOI: 10.1016/j.expneurol.2020.113284

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 gangliosidePMID 32165255Read ↗

Mice Lacking Major Brain Gangliosides Develop ParkinsonismSemantic proximity Read ↗

The Key Role of GM1 Ganglioside in Parkinson’s DiseaseSemantic proximity Read ↗

Synthetic GM1 improves motor and memory dysfunctions in mice with monoallelic or biallelic disruption of GM3 synthaseSemantic proximity Read ↗

A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation.Semantic proximity Read ↗

GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.Semantic proximity Read ↗

Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B.Semantic proximity Read ↗

Gene therapy approaches for GM1 gangliosidosis: Focus on animal and cellular studies.Semantic proximity Read ↗

A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy.Semantic proximity Read ↗

A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) MiceSemantic proximity Read ↗

siRNA-mediated knockdown of B3GALT4 decreases GM1 ganglioside expression and enhances vulnerability for neurodegenerationSemantic proximity Read ↗

The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.Semantic proximity Read ↗

Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.